Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with ZBIO: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
ZBIO
Zenas BioPharma, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
ZBIO
Zenas BioPharma, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ZBIO: latest quarter is a loss; flow not drawable.
Method
›
LLY
ELI Lilly & Co
Change
1,381.35
▼
−2.58%
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
ZBIO
Zenas BioPharma, Inc.
Change
26.81
▼
−5.79%
Regular session
Nov 5 '26
Mkt cap
$1.8B
Revenue
$10M
Q3 FY26
Revenue
—
vs
Compare
Regular session
Nov 5 '26
LLY
ELI Lilly & Co
vs
ZBIO
Zenas BioPharma, Inc.
1,381.35
▼
−2.58%
Price
26.81
▼
−5.79%
$1.3T
Mkt cap
$1.8B
Q3 FY26
$24.4B
Revenue
$10M
Q3 FY26
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,381.35
▼
−2.58%
vs
ZBIO
26.81
▼
−5.79%
Regular session
Nov 5 '26
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only ZBIO
10
BMY
Bristol-Myers Squibb
customer
XNCR
Xencor
supplier
—
InnoCare
unlisted
supplier
—
WuXi Biologics
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
unlisted
supplier
6 more · ZBIO chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
ZBIO, dashed